Tarsus Announces Proposed $100.0 Million Public Offering : vimarsana.com

IRVINE, Calif., Feb. 29, 2024 -- Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,...

Related Keywords

North Carolina , United States , New York , Charlotte , Adrienne Kemp , David Nakasone , Exchange Commission , Syndicate Prospectus Department , Prospectus Department , Oppenheimer Co , Nasdaq , Goldman Sachs Co , Corporate Communications , Tarsus Pharmaceuticals Inc , Company Or Tarsus , Equity Syndicate Department , Guggenheim Securities , Bofa Securities , Goldman Sachs , Tryon Street , Tarsus Pharmaceuticals , Meibomian Gland Disease , Tarsu Form ,